WallStSmart

Kellanova (K)vsNiagen Bioscience, Inc. (NAGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kellanova generates 9715% more annual revenue ($12.67B vs $129.08M). NAGE leads profitability with a 12.4% profit margin vs 0.1%. NAGE trades at a lower P/E of 16.0x. K earns a higher WallStSmart Score of 50/100 (C-).

K

Buy

50

out of 100

Grade: C-

Growth: 3.3Profit: 4.0Value: 4.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.20

NAGE

Hold

40

out of 100

Grade: D

Growth: 4.7Profit: 6.0Value: 6.0Quality: 8.5
Piotroski: 4/9Altman Z: 2.02

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

K0 strengths · Avg: 0/10

No standout strengths identified

NAGE4 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Return on EquityProfitability
22.6%9/10

Every $100 of equity generates 23 in profit

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Areas to Watch

K4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Return on EquityProfitability
0.3%3/10

ROE of 0.3% — below average capital efficiency

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

Operating MarginProfitability
0.1%3/10

Operating margin of 0.1%

NAGE4 concerns · Avg: 2.5/10
Market CapQuality
$240.15M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.4%3/10

Operating margin of 2.4%

Revenue GrowthGrowth
-4.3%2/10

Revenue declined 4.3%

EPS GrowthGrowth
-75.0%2/10

Earnings declined 75.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : K

K has a balanced fundamental profile.

Bull Case : NAGE

The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.

Bear Case : K

The primary concerns for K are Revenue Growth, Return on Equity, Profit Margin. Thin 0.1% margins leave little buffer for downturns.

Bear Case : NAGE

The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.

Key Dynamics to Monitor

K profiles as a value stock while NAGE is a declining play — different risk/reward profiles.

NAGE carries more volatility with a beta of 2.09 — expect wider price swings.

K is growing revenue faster at 0.0% — sustainability is the question.

K generates stronger free cash flow (359M), providing more financial flexibility.

Bottom Line

K scores higher overall (50/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kellanova

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

The Kellogg Company, doing business as Kellogg's, is an American multinational food manufacturing company headquartered in Battle Creek, Michigan, United States.

Niagen Bioscience, Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.

Want to dig deeper into these stocks?